Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02943941 · ClinicalTrials.gov registry record · NA

Pressure Variability Study

A NA study of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
NA
Development phase
16
Enrollment target
2
Study locations

NCT02943941: Completed NA study of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

NCT02943941 is a NA study of Heart Failure that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 16 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02943941, a NA study of Heart Failure, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to understand how the pressure in the pulmonary artery changes under different conditions of posture, respiration and exertion.

Conditions Studied

Interventions

  • OTHER Reveal LINQ ICM Cardiac Monitor, taped on the subject's chest rather than inserted in the body.

Study Locations (2)

California

  • University of California, San Francisco - San Francisco

Ohio

  • The Lindner Research Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2016-07
Est. Completion 2017-01
Phase NA

What the Registry Record Tells You About NCT02943941

The ClinicalTrials.gov registry entry for NCT02943941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Reveal LINQ ICM Cardiac Monitor, taped on the subject's chest rather than inserted in the body. is the first listed.

NCT02943941 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Ohio.

Frequently Asked Questions

What is clinical trial NCT02943941 about?

NCT02943941 is a clinical study titled "Pressure Variability Study". The purpose of this study is to understand how the pressure in the pulmonary artery changes under different conditions of posture, respiration and exertion.

What is the current status of trial NCT02943941?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-07. Estimated completion is 2017-01.

What conditions does trial NCT02943941 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT02943941?

The interventions under investigation include: Reveal LINQ ICM Cardiac Monitor, taped on the subject's chest rather than inserted in the body. (OTHER).

Who is sponsoring clinical trial NCT02943941?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02943941 being conducted?

This trial has 2 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.